| 0 |
FLUORIDE INCREASED |
43 |
0.8113 |
| 1 |
PERIOSTITIS |
236 |
0.5463 |
| 2 |
FLUOROSIS |
44 |
0.5116 |
| 3 |
CEREBRAL ASPERGILLOSIS |
200 |
0.3252 |
| 4 |
HYPERTROPHIC OSTEOARTHROPATHY |
21 |
0.3088 |
| 5 |
GEOTRICHUM INFECTION |
61 |
0.2891 |
| 6 |
MYCOTIC ENDOPHTHALMITIS |
47 |
0.2487 |
| 7 |
SCEDOSPORIUM INFECTION |
174 |
0.2465 |
| 8 |
FUSARIUM INFECTION |
160 |
0.2286 |
| 9 |
CHLOROPSIA |
26 |
0.2031 |
| 10 |
CENTRAL NERVOUS SYSTEM FUNGAL INFECTION |
47 |
0.2026 |
| 11 |
PHOTODERMATOSIS |
84 |
0.1991 |
| 12 |
CHOROIDITIS |
72 |
0.1925 |
| 13 |
FUNGAL ENDOCARDITIS |
56 |
0.1860 |
| 14 |
DISSEMINATED ASPERGILLOSIS |
87 |
0.1843 |
| 15 |
DISSEMINATED MUCORMYCOSIS |
69 |
0.1751 |
| 16 |
ASPERGILLOMA |
56 |
0.1750 |
| 17 |
OSTEOMYELITIS FUNGAL |
29 |
0.1737 |
| 18 |
ASPERGILLUS TEST POSITIVE |
52 |
0.1688 |
| 19 |
KERATITIS FUNGAL |
35 |
0.1683 |
| 20 |
PULMONARY MUCORMYCOSIS |
86 |
0.1629 |
| 21 |
ZYGOMYCOSIS |
73 |
0.1560 |
| 22 |
SYSTEMIC MYCOSIS |
176 |
0.1507 |
| 23 |
DILATATION INTRAHEPATIC DUCT ACQUIRED |
42 |
0.1438 |
| 24 |
ASPERGILLUS INFECTION |
943 |
0.1435 |
| 25 |
TOXIC OPTIC NEUROPATHY |
61 |
0.1406 |
| 26 |
MUCORMYCOSIS |
360 |
0.1384 |
| 27 |
ABSCESS FUNGAL |
24 |
0.1371 |
| 28 |
BRONCHOPULMONARY ASPERGILLOSIS |
1063 |
0.1370 |
| 29 |
LIP SQUAMOUS CELL CARCINOMA |
21 |
0.1250 |
| 30 |
XANTHOPSIA |
46 |
0.1247 |
| 31 |
CEREBRAL FUNGAL INFECTION |
33 |
0.1166 |
| 32 |
TRICHOSPORON INFECTION |
47 |
0.1160 |
| 33 |
ACTINIC KERATOSIS |
297 |
0.1143 |
| 34 |
ASPERGILLOSIS |
143 |
0.1094 |
| 35 |
EYE INFECTION FUNGAL |
39 |
0.1008 |
| 36 |
TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT |
18 |
0.0994 |
| 37 |
PHAEOHYPHOMYCOSIS |
46 |
0.0960 |
| 38 |
ACANTHAMOEBA INFECTION |
18 |
0.0957 |
| 39 |
DYSPLASTIC NAEVUS |
34 |
0.0942 |
| 40 |
MICROSPORIDIA INFECTION |
33 |
0.0940 |
| 41 |
ALTERNARIA INFECTION |
34 |
0.0914 |
| 42 |
CYSTITIS VIRAL |
34 |
0.0888 |
| 43 |
DEHISCENCE |
16 |
0.0847 |
| 44 |
IDIOPATHIC PNEUMONIA SYNDROME |
24 |
0.0805 |
| 45 |
LOWER RESPIRATORY TRACT INFECTION FUNGAL |
31 |
0.0797 |
| 46 |
BLOOD BETA-D-GLUCAN INCREASED |
24 |
0.0782 |
| 47 |
PULMONARY MYCOSIS |
58 |
0.0745 |
| 48 |
FUNGAL TEST POSITIVE |
26 |
0.0741 |
| 49 |
PNEUMONIA FUNGAL |
290 |
0.0734 |
| 50 |
SKIN CANDIDA |
38 |
0.0728 |
| 51 |
FUNGAEMIA |
111 |
0.0705 |
| 52 |
PSEUDOPORPHYRIA |
23 |
0.0673 |
| 53 |
DISORGANISED SPEECH |
122 |
0.0661 |
| 54 |
SOLAR LENTIGO |
61 |
0.0643 |
| 55 |
ACUTE GRAFT VERSUS HOST DISEASE IN LIVER |
45 |
0.0626 |
| 56 |
GALLBLADDER OEDEMA |
18 |
0.0614 |
| 57 |
DYSCHROMATOPSIA |
48 |
0.0579 |
| 58 |
PNEUMOCYSTIS JIROVECII INFECTION |
68 |
0.0569 |
| 59 |
MEDIASTINITIS |
33 |
0.0569 |
| 60 |
INFECTIVE ANEURYSM |
28 |
0.0566 |
| 61 |
LENTIGO |
28 |
0.0565 |
| 62 |
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE |
79 |
0.0559 |
| 63 |
SQUAMOUS CELL CARCINOMA OF SKIN |
336 |
0.0556 |
| 64 |
RHINOCEREBRAL MUCORMYCOSIS |
19 |
0.0548 |
| 65 |
LUNG TRANSPLANT REJECTION |
35 |
0.0530 |
| 66 |
GRAFT VERSUS HOST DISEASE IN LUNG |
25 |
0.0523 |
| 67 |
BRAIN ABSCESS |
131 |
0.0517 |
| 68 |
HUMAN POLYOMAVIRUS INFECTION |
27 |
0.0508 |
| 69 |
VIRAL HAEMORRHAGIC CYSTITIS |
36 |
0.0506 |
| 70 |
PNEUMONIA NECROTISING |
32 |
0.0495 |
| 71 |
PRODUCT COMPOUNDING QUALITY ISSUE |
18 |
0.0493 |
| 72 |
POLYSEROSITIS |
21 |
0.0493 |
| 73 |
RESPIRATORY TRACT INFECTION FUNGAL |
26 |
0.0492 |
| 74 |
CITROBACTER INFECTION |
21 |
0.0490 |
| 75 |
SINUSITIS FUNGAL |
39 |
0.0486 |
| 76 |
ENTEROCOCCAL SEPSIS |
39 |
0.0481 |
| 77 |
SEPTIC EMBOLUS |
40 |
0.0481 |
| 78 |
CHROMATOPSIA |
35 |
0.0461 |
| 79 |
STENOTROPHOMONAS INFECTION |
62 |
0.0457 |
| 80 |
TRACHEOBRONCHITIS |
34 |
0.0442 |
| 81 |
IMMUNOSUPPRESSANT DRUG LEVEL INCREASED |
144 |
0.0436 |
| 82 |
BLASTOMYCOSIS |
21 |
0.0432 |
| 83 |
GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT |
90 |
0.0423 |
| 84 |
UREAPLASMA INFECTION |
17 |
0.0417 |
| 85 |
DRUG LEVEL BELOW THERAPEUTIC |
229 |
0.0415 |
| 86 |
ACUTE MYELOID LEUKAEMIA RECURRENT |
89 |
0.0414 |
| 87 |
GRAFT VERSUS HOST DISEASE |
297 |
0.0413 |
| 88 |
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN |
114 |
0.0412 |
| 89 |
DISSEMINATED CRYPTOCOCCOSIS |
31 |
0.0410 |
| 90 |
GLIOSIS |
17 |
0.0396 |
| 91 |
INFECTION IN AN IMMUNOCOMPROMISED HOST |
28 |
0.0390 |
| 92 |
GRAFT VERSUS HOST DISEASE IN SKIN |
85 |
0.0385 |
| 93 |
CORNEAL PERFORATION |
24 |
0.0380 |
| 94 |
PULMONARY CAVITATION |
33 |
0.0379 |
| 95 |
LEUKAEMIA RECURRENT |
64 |
0.0378 |
| 96 |
PHOTOSENSITIVITY REACTION |
624 |
0.0377 |
| 97 |
GRAFT VERSUS HOST DISEASE IN LIVER |
27 |
0.0377 |
| 98 |
OVARIAN FAILURE |
20 |
0.0374 |
| 99 |
DRUG LEVEL INCREASED |
619 |
0.0374 |
| 100 |
ENTEROCOCCAL BACTERAEMIA |
39 |
0.0368 |
| 101 |
RENAL ISCHAEMIA |
20 |
0.0366 |
| 102 |
DYSBIOSIS |
30 |
0.0365 |
| 103 |
HALO VISION |
40 |
0.0354 |
| 104 |
MYCOBACTERIUM ABSCESSUS INFECTION |
25 |
0.0350 |
| 105 |
NECROTISING RETINITIS |
22 |
0.0344 |
| 106 |
CYTOMEGALOVIRUS ENTEROCOLITIS |
26 |
0.0338 |
| 107 |
GASTROINTESTINAL FUNGAL INFECTION |
17 |
0.0330 |
| 108 |
TOXOPLASMOSIS |
35 |
0.0324 |
| 109 |
BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC |
30 |
0.0324 |
| 110 |
SYSTEMIC CANDIDA |
77 |
0.0306 |
| 111 |
DRUG LEVEL ABOVE THERAPEUTIC |
138 |
0.0301 |
| 112 |
FUNGAL SEPSIS |
25 |
0.0301 |
| 113 |
RETINAL ISCHAEMIA |
18 |
0.0295 |
| 114 |
RENAL ABSCESS |
24 |
0.0293 |
| 115 |
ENTEROCOCCAL INFECTION |
138 |
0.0285 |
| 116 |
ACINETOBACTER INFECTION |
31 |
0.0283 |
| 117 |
PNEUMONIA PSEUDOMONAL |
43 |
0.0280 |
| 118 |
PATHOGEN RESISTANCE |
252 |
0.0276 |
| 119 |
PROCALCITONIN INCREASED |
32 |
0.0273 |
| 120 |
ENGRAFTMENT SYNDROME |
16 |
0.0271 |
| 121 |
CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN |
25 |
0.0270 |
| 122 |
ACUTE GRAFT VERSUS HOST DISEASE |
122 |
0.0266 |
| 123 |
ENDOPHTHALMITIS |
159 |
0.0265 |
| 124 |
INFECTIOUS PLEURAL EFFUSION |
40 |
0.0263 |
| 125 |
MICROANGIOPATHIC HAEMOLYTIC ANAEMIA |
20 |
0.0254 |
| 126 |
CYTOMEGALOVIRUS VIRAEMIA |
112 |
0.0252 |
| 127 |
PRODUCT CONTAMINATION MICROBIAL |
30 |
0.0251 |
| 128 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
712 |
0.0251 |
| 129 |
IMMUNOSUPPRESSANT DRUG LEVEL DECREASED |
30 |
0.0250 |
| 130 |
VENOOCCLUSIVE LIVER DISEASE |
122 |
0.0247 |
| 131 |
HALLUCINATION, VISUAL |
516 |
0.0244 |
| 132 |
COCCIDIOIDOMYCOSIS |
29 |
0.0243 |
| 133 |
PNEUMONIA CYTOMEGALOVIRAL |
47 |
0.0242 |
| 134 |
SQUAMOUS CELL CARCINOMA |
225 |
0.0239 |
| 135 |
DRUG RESISTANCE |
612 |
0.0238 |
| 136 |
PSEUDOMONAS INFECTION |
204 |
0.0238 |
| 137 |
DRUG LEVEL DECREASED |
240 |
0.0236 |
| 138 |
DIFFERENTIATION SYNDROME |
17 |
0.0232 |
| 139 |
INFECTION REACTIVATION |
26 |
0.0227 |
| 140 |
BK VIRUS INFECTION |
76 |
0.0225 |
| 141 |
CHRONIC GRAFT VERSUS HOST DISEASE |
81 |
0.0224 |
| 142 |
PNEUMONIA CRYPTOCOCCAL |
21 |
0.0222 |
| 143 |
OBLITERATIVE BRONCHIOLITIS |
29 |
0.0221 |
| 144 |
APALLIC SYNDROME |
16 |
0.0220 |
| 145 |
NOCARDIOSIS |
56 |
0.0219 |
| 146 |
ACUTE MYELOID LEUKAEMIA |
340 |
0.0218 |
| 147 |
NEUROLOGICAL DECOMPENSATION |
50 |
0.0216 |
| 148 |
PNEUMOMEDIASTINUM |
39 |
0.0216 |
| 149 |
LUNG ABSCESS |
45 |
0.0214 |
| 150 |
KLEBSIELLA SEPSIS |
24 |
0.0213 |
| 151 |
ACUTE LYMPHOCYTIC LEUKAEMIA |
60 |
0.0212 |
| 152 |
PSEUDOMONAL BACTERAEMIA |
18 |
0.0211 |
| 153 |
APLASIA |
41 |
0.0209 |
| 154 |
POUCHITIS |
18 |
0.0209 |
| 155 |
CYTOMEGALOVIRUS TEST POSITIVE |
37 |
0.0207 |
| 156 |
ADENOVIRUS INFECTION |
60 |
0.0207 |
| 157 |
PULMONARY NOCARDIOSIS |
17 |
0.0206 |
| 158 |
ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT |
53 |
0.0205 |
| 159 |
HEPATOTOXICITY |
443 |
0.0199 |
| 160 |
CYTOMEGALOVIRUS INFECTION REACTIVATION |
87 |
0.0197 |
| 161 |
COLOUR BLINDNESS |
18 |
0.0196 |
| 162 |
CYSTITIS HAEMORRHAGIC |
79 |
0.0196 |
| 163 |
KLEBSIELLA INFECTION |
99 |
0.0196 |
| 164 |
BLAST CELL COUNT INCREASED |
20 |
0.0191 |
| 165 |
PSEUDOMONAL SEPSIS |
33 |
0.0188 |
| 166 |
BACTERIAL SEPSIS |
61 |
0.0187 |
| 167 |
CHOLESTASIS |
359 |
0.0187 |
| 168 |
PREMATURE MENOPAUSE |
17 |
0.0184 |
| 169 |
BRAIN HERNIATION |
55 |
0.0184 |
| 170 |
DRUG CLEARANCE DECREASED |
24 |
0.0184 |
| 171 |
OCULAR TOXICITY |
20 |
0.0181 |
| 172 |
HUMAN HERPESVIRUS 6 INFECTION |
34 |
0.0180 |
| 173 |
VENOOCCLUSIVE DISEASE |
45 |
0.0180 |
| 174 |
KLEBSIELLA BACTERAEMIA |
17 |
0.0179 |
| 175 |
HYPOGONADISM |
18 |
0.0178 |
| 176 |
MYCOBACTERIUM AVIUM COMPLEX INFECTION |
47 |
0.0175 |
| 177 |
CAPILLARY LEAK SYNDROME |
36 |
0.0174 |
| 178 |
FUNGAL INFECTION |
580 |
0.0174 |
| 179 |
MIXED LIVER INJURY |
52 |
0.0173 |
| 180 |
CRYPTOCOCCOSIS |
28 |
0.0172 |
| 181 |
FUNGAL SKIN INFECTION |
69 |
0.0171 |
| 182 |
MUCOSAL ULCERATION |
17 |
0.0168 |
| 183 |
LUNG CONSOLIDATION |
47 |
0.0168 |
| 184 |
STREPTOCOCCAL BACTERAEMIA |
18 |
0.0165 |
| 185 |
SEPTIC SHOCK |
718 |
0.0165 |
| 186 |
STEM CELL TRANSPLANT |
41 |
0.0164 |
| 187 |
POTENTIATING DRUG INTERACTION |
55 |
0.0164 |
| 188 |
BONE MARROW TRANSPLANT |
31 |
0.0163 |
| 189 |
CHOLESTATIC LIVER INJURY |
36 |
0.0162 |
| 190 |
GASTROINTESTINAL WALL THICKENING |
24 |
0.0160 |
| 191 |
MENINGITIS CRYPTOCOCCAL |
28 |
0.0160 |
| 192 |
PULMONARY ALVEOLAR HAEMORRHAGE |
89 |
0.0159 |
| 193 |
PNEUMONIA KLEBSIELLA |
29 |
0.0158 |
| 194 |
SOMATIC SYMPTOM DISORDER |
17 |
0.0157 |
| 195 |
NEUROTOXICITY |
273 |
0.0156 |
| 196 |
POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER |
79 |
0.0155 |
| 197 |
DRUG INTERACTION |
2410 |
0.0152 |
| 198 |
TORSADE DE POINTES |
119 |
0.0152 |
| 199 |
PARAINFLUENZAE VIRUS INFECTION |
23 |
0.0151 |
| 200 |
ENTEROBACTER INFECTION |
25 |
0.0149 |
| 201 |
STRONGYLOIDIASIS |
24 |
0.0148 |
| 202 |
HEPATOSPLENOMEGALY |
38 |
0.0148 |
| 203 |
LUNG OPACITY |
39 |
0.0148 |
| 204 |
CEREBRAL ARTERY EMBOLISM |
18 |
0.0148 |
| 205 |
HYPOPROTEINAEMIA |
28 |
0.0147 |
| 206 |
NEPHROPATHY TOXIC |
165 |
0.0147 |
| 207 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
109 |
0.0145 |
| 208 |
LABELLED DRUG-DRUG INTERACTION ISSUE |
21 |
0.0145 |
| 209 |
CYTOMEGALOVIRUS INFECTION |
241 |
0.0145 |
| 210 |
STAPHYLOCOCCAL SEPSIS |
71 |
0.0144 |
| 211 |
HEPATITIS CHOLESTATIC |
86 |
0.0143 |
| 212 |
NECROTISING COLITIS |
18 |
0.0142 |
| 213 |
EMPYEMA |
28 |
0.0141 |
| 214 |
ESCHERICHIA BACTERAEMIA |
33 |
0.0140 |
| 215 |
NEUTROPENIC COLITIS |
29 |
0.0140 |
| 216 |
FEBRILE NEUTROPENIA |
925 |
0.0139 |
| 217 |
INHIBITORY DRUG INTERACTION |
22 |
0.0139 |
| 218 |
PSEUDOMEMBRANOUS COLITIS |
31 |
0.0139 |
| 219 |
ACUTE LEUKAEMIA |
22 |
0.0136 |
| 220 |
CARDIOVASCULAR INSUFFICIENCY |
22 |
0.0135 |
| 221 |
ACUTE LUNG INJURY |
16 |
0.0135 |
| 222 |
HEPATIC CYTOLYSIS |
172 |
0.0135 |
| 223 |
PULMONARY HAEMORRHAGE |
104 |
0.0133 |
| 224 |
PNEUMONIA BACTERIAL |
122 |
0.0133 |
| 225 |
MULTI-ORGAN FAILURE |
228 |
0.0132 |
| 226 |
PNEUMONIA LEGIONELLA |
21 |
0.0131 |
| 227 |
ESCHERICHIA SEPSIS |
38 |
0.0131 |
| 228 |
DISSEMINATED INTRAVASCULAR COAGULATION |
184 |
0.0131 |
| 229 |
HYPERTRANSAMINASAEMIA |
90 |
0.0129 |
| 230 |
CANDIDA INFECTION |
218 |
0.0129 |
| 231 |
NEUTROPENIC SEPSIS |
92 |
0.0129 |
| 232 |
SUSPECTED OFF LABEL USE |
58 |
0.0128 |
| 233 |
BILIRUBIN CONJUGATED INCREASED |
30 |
0.0128 |
| 234 |
ATYPICAL MYCOBACTERIAL INFECTION |
18 |
0.0127 |
| 235 |
LEUKAEMIA |
120 |
0.0127 |
| 236 |
TOXIC ENCEPHALOPATHY |
64 |
0.0126 |
| 237 |
BRONCHIAL SECRETION RETENTION |
16 |
0.0126 |
| 238 |
INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS |
68 |
0.0125 |
| 239 |
CANDIDIASIS |
50 |
0.0125 |
| 240 |
HISTOPLASMOSIS |
22 |
0.0124 |
| 241 |
COMA SCALE ABNORMAL |
36 |
0.0124 |
| 242 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
218 |
0.0123 |
| 243 |
APRAXIA |
18 |
0.0121 |
| 244 |
CHEILITIS |
65 |
0.0120 |
| 245 |
THROMBOTIC MICROANGIOPATHY |
117 |
0.0120 |
| 246 |
MULTIPLE-DRUG RESISTANCE |
37 |
0.0119 |
| 247 |
RESPIRATORY FAILURE |
867 |
0.0119 |
| 248 |
PNEUMONIA STAPHYLOCOCCAL |
23 |
0.0116 |
| 249 |
HEPATIC FUNCTION ABNORMAL |
435 |
0.0116 |
| 250 |
ENTHESOPATHY |
18 |
0.0115 |
| 251 |
COMPLICATIONS OF TRANSPLANTED KIDNEY |
26 |
0.0115 |
| 252 |
HISTIOCYTOSIS HAEMATOPHAGIC |
34 |
0.0114 |
| 253 |
TRANSPLANT FAILURE |
28 |
0.0114 |
| 254 |
HALLUCINATIONS, MIXED |
48 |
0.0114 |
| 255 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
30 |
0.0113 |
| 256 |
DYSPHORIA |
57 |
0.0113 |
| 257 |
TRANSPLANT DYSFUNCTION |
20 |
0.0112 |
| 258 |
ILEUS PARALYTIC |
50 |
0.0112 |
| 259 |
ANTIPHOSPHOLIPID SYNDROME |
18 |
0.0112 |
| 260 |
CYTOLYTIC HEPATITIS |
37 |
0.0111 |
| 261 |
LUNG INFILTRATION |
98 |
0.0111 |
| 262 |
STAPHYLOCOCCAL BACTERAEMIA |
48 |
0.0110 |
| 263 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
105 |
0.0110 |
| 264 |
NEUROLOGICAL SYMPTOM |
62 |
0.0108 |
| 265 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
240 |
0.0108 |
| 266 |
NECROSIS |
60 |
0.0108 |
| 267 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
110 |
0.0107 |
| 268 |
SPUTUM INCREASED |
23 |
0.0106 |
| 269 |
DEAFNESS BILATERAL |
18 |
0.0106 |
| 270 |
HEPATOCELLULAR INJURY |
150 |
0.0106 |
| 271 |
LUNG INFECTION |
164 |
0.0105 |
| 272 |
RHINOVIRUS INFECTION |
41 |
0.0105 |
| 273 |
ASPARTATE AMINOTRANSFERASE ABNORMAL |
16 |
0.0105 |
| 274 |
MYCOBACTERIAL INFECTION |
18 |
0.0104 |
| 275 |
HYPERLACTACIDAEMIA |
28 |
0.0104 |
| 276 |
DEVICE RELATED SEPSIS |
21 |
0.0104 |
| 277 |
GRANULOMA |
36 |
0.0104 |
| 278 |
SOFT TISSUE INFECTION |
19 |
0.0104 |
| 279 |
ORGANISING PNEUMONIA |
51 |
0.0103 |
| 280 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
255 |
0.0103 |
| 281 |
BURNS SECOND DEGREE |
18 |
0.0103 |
| 282 |
CYTOMEGALOVIRUS CHORIORETINITIS |
20 |
0.0102 |
| 283 |
TRANSPLANT REJECTION |
82 |
0.0102 |
| 284 |
HYPERBILIRUBINAEMIA |
106 |
0.0102 |
| 285 |
LEUKOENCEPHALOPATHY |
38 |
0.0102 |
| 286 |
PANCYTOPENIA |
570 |
0.0102 |
| 287 |
PHOTOPSIA |
64 |
0.0101 |
| 288 |
CELL DEATH |
20 |
0.0101 |
| 289 |
INTERVERTEBRAL DISCITIS |
19 |
0.0101 |
| 290 |
APLASTIC ANAEMIA |
52 |
0.0099 |
| 291 |
FORCED EXPIRATORY VOLUME DECREASED |
28 |
0.0099 |
| 292 |
LIVER ABSCESS |
32 |
0.0099 |
| 293 |
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME |
49 |
0.0098 |
| 294 |
SKIN NECROSIS |
51 |
0.0098 |
| 295 |
VENOUS THROMBOSIS LIMB |
20 |
0.0097 |
| 296 |
BLOOD CULTURE POSITIVE |
29 |
0.0097 |
| 297 |
OLIGURIA |
60 |
0.0097 |
| 298 |
HAEMOTHORAX |
28 |
0.0096 |
| 299 |
DRUG-INDUCED LIVER INJURY |
301 |
0.0096 |
| 300 |
CEREBELLAR SYNDROME |
21 |
0.0096 |
| 301 |
BLOOD BILIRUBIN INCREASED |
257 |
0.0095 |
| 302 |
HALLUCINATION |
715 |
0.0095 |
| 303 |
CHEST X-RAY ABNORMAL |
29 |
0.0094 |
| 304 |
HAEMODYNAMIC INSTABILITY |
72 |
0.0094 |
| 305 |
HYPERAMMONAEMIA |
47 |
0.0094 |
| 306 |
STUPOR |
30 |
0.0093 |
| 307 |
PULMONARY MASS |
139 |
0.0093 |
| 308 |
METABOLIC ENCEPHALOPATHY |
28 |
0.0093 |
| 309 |
TUMOUR LYSIS SYNDROME |
82 |
0.0093 |
| 310 |
DELIRIUM |
321 |
0.0092 |
| 311 |
RENAL TUBULAR DISORDER |
26 |
0.0092 |
| 312 |
HYPOPHOSPHATAEMIA |
67 |
0.0091 |
| 313 |
LUNG TRANSPLANT |
32 |
0.0090 |
| 314 |
CYTOPENIA |
110 |
0.0090 |
| 315 |
HYPERCAPNIA |
27 |
0.0090 |
| 316 |
INFLAMMATORY MARKER INCREASED |
44 |
0.0089 |
| 317 |
HEPATITIS TOXIC |
23 |
0.0088 |
| 318 |
EPSTEIN-BARR VIRUS INFECTION |
55 |
0.0088 |
| 319 |
DERMATITIS EXFOLIATIVE |
44 |
0.0088 |
| 320 |
BACTERAEMIA |
104 |
0.0088 |
| 321 |
CYTOKINE RELEASE SYNDROME |
175 |
0.0087 |
| 322 |
BLOOD IMMUNOGLOBULIN E INCREASED |
21 |
0.0087 |
| 323 |
RESPIRATORY ACIDOSIS |
34 |
0.0086 |
| 324 |
HAEMOPTYSIS |
239 |
0.0086 |
| 325 |
STAPHYLOCOCCUS TEST POSITIVE |
18 |
0.0085 |
| 326 |
PNEUMOTHORAX |
135 |
0.0085 |
| 327 |
TORTICOLLIS |
18 |
0.0085 |
| 328 |
BONE MARROW FAILURE |
171 |
0.0084 |
| 329 |
BASAL CELL CARCINOMA |
130 |
0.0083 |
| 330 |
CLOSTRIDIUM DIFFICILE COLITIS |
88 |
0.0083 |
| 331 |
ALTERED STATE OF CONSCIOUSNESS |
179 |
0.0083 |
| 332 |
RENAL TUBULAR ACIDOSIS |
18 |
0.0082 |
| 333 |
TOXIC SKIN ERUPTION |
83 |
0.0082 |
| 334 |
BRAIN OEDEMA |
104 |
0.0082 |
| 335 |
HYPOALBUMINAEMIA |
64 |
0.0082 |
| 336 |
VISUAL DISTURBANCE |
47 |
0.0082 |
| 337 |
ENCEPHALOPATHY |
201 |
0.0082 |
| 338 |
HERPES SIMPLEX |
53 |
0.0081 |
| 339 |
HYPOXIA |
285 |
0.0081 |
| 340 |
LIVER FUNCTION TEST ABNORMAL |
233 |
0.0080 |
| 341 |
ELECTROCARDIOGRAM QT PROLONGED |
288 |
0.0080 |
| 342 |
FEBRILE BONE MARROW APLASIA |
34 |
0.0080 |
| 343 |
CARDIAC TAMPONADE |
38 |
0.0080 |
| 344 |
HYPOKALAEMIA |
369 |
0.0080 |
| 345 |
ENCEPHALITIS |
55 |
0.0079 |
| 346 |
ENDOCARDITIS |
40 |
0.0078 |
| 347 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
78 |
0.0078 |
| 348 |
LIP BLISTER |
21 |
0.0077 |
| 349 |
TRANSAMINASES INCREASED |
171 |
0.0077 |
| 350 |
HYPOMAGNESAEMIA |
107 |
0.0077 |
| 351 |
POLYOMAVIRUS-ASSOCIATED NEPHROPATHY |
18 |
0.0077 |
| 352 |
MYOCLONUS |
91 |
0.0076 |
| 353 |
HYPERNATRAEMIA |
38 |
0.0076 |
| 354 |
DERMATITIS BULLOUS |
55 |
0.0076 |
| 355 |
CACHEXIA |
39 |
0.0076 |
| 356 |
TRANSPLANT |
18 |
0.0076 |
| 357 |
LONG QT SYNDROME |
18 |
0.0075 |
| 358 |
JAUNDICE CHOLESTATIC |
26 |
0.0074 |
| 359 |
ULCERATIVE KERATITIS |
20 |
0.0073 |
| 360 |
CHOLECYSTITIS ACUTE |
41 |
0.0072 |
| 361 |
ORGAN FAILURE |
29 |
0.0072 |
| 362 |
VENTRICULAR HYPOKINESIA |
23 |
0.0072 |
| 363 |
MUCOSAL INFLAMMATION |
187 |
0.0071 |
| 364 |
BACTERIAL INFECTION |
133 |
0.0071 |
| 365 |
PULMONARY FUNCTION TEST DECREASED |
31 |
0.0071 |
| 366 |
HEPATITIS FULMINANT |
21 |
0.0071 |
| 367 |
PHOTOPHOBIA |
131 |
0.0070 |
| 368 |
CYTOMEGALOVIRUS COLITIS |
16 |
0.0070 |
| 369 |
IMMUNOSUPPRESSION |
61 |
0.0069 |
| 370 |
MYELODYSPLASTIC SYNDROME |
100 |
0.0069 |
| 371 |
HYPOGAMMAGLOBULINAEMIA |
45 |
0.0068 |
| 372 |
PERSECUTORY DELUSION |
17 |
0.0068 |
| 373 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
372 |
0.0068 |
| 374 |
RETINAL HAEMORRHAGE |
48 |
0.0067 |
| 375 |
COAGULOPATHY |
112 |
0.0067 |
| 376 |
LYMPHOPENIA |
95 |
0.0067 |
| 377 |
RALES |
39 |
0.0067 |
| 378 |
CYSTIC FIBROSIS |
37 |
0.0067 |
| 379 |
BLOOD ALBUMIN DECREASED |
53 |
0.0067 |
| 380 |
ACIDOSIS |
51 |
0.0067 |
| 381 |
ABDOMINAL INFECTION |
17 |
0.0066 |
| 382 |
FUNCTIONAL GASTROINTESTINAL DISORDER |
23 |
0.0066 |
| 383 |
NEUTROPHIL COUNT DECREASED |
271 |
0.0066 |
| 384 |
HYDROCEPHALUS |
36 |
0.0066 |
| 385 |
GASTRIC PERFORATION |
18 |
0.0066 |
| 386 |
TOXIC EPIDERMAL NECROLYSIS |
100 |
0.0066 |
| 387 |
STAPHYLOCOCCAL INFECTION |
217 |
0.0066 |
| 388 |
HYPERURICAEMIA |
27 |
0.0066 |
| 389 |
RASH MACULO-PAPULAR |
146 |
0.0066 |
| 390 |
CUSHINGOID |
21 |
0.0065 |
| 391 |
THROMBOTIC THROMBOCYTOPENIC PURPURA |
23 |
0.0065 |
| 392 |
ATELECTASIS |
63 |
0.0065 |
| 393 |
HEPATOMEGALY |
64 |
0.0065 |
| 394 |
PERIPHERAL SENSORY NEUROPATHY |
38 |
0.0065 |
| 395 |
SUNBURN |
48 |
0.0064 |
| 396 |
BRONCHOPNEUMONIA |
22 |
0.0064 |
| 397 |
SEPSIS |
714 |
0.0064 |
| 398 |
ORAL INFECTION |
25 |
0.0064 |
| 399 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
101 |
0.0064 |
| 400 |
PROTEIN TOTAL DECREASED |
24 |
0.0064 |
| 401 |
ARTHRITIS BACTERIAL |
26 |
0.0063 |
| 402 |
HEPATIC FAILURE |
189 |
0.0063 |
| 403 |
ASPARTATE AMINOTRANSFERASE INCREASED |
332 |
0.0062 |
| 404 |
LIVER INJURY |
151 |
0.0061 |
| 405 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
31 |
0.0061 |
| 406 |
ELECTROLYTE IMBALANCE |
71 |
0.0061 |
| 407 |
LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR |
54 |
0.0061 |
| 408 |
TACHYPNOEA |
83 |
0.0061 |
| 409 |
PLEURAL EFFUSION |
369 |
0.0061 |
| 410 |
MENTAL STATUS CHANGES |
168 |
0.0060 |
| 411 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
23 |
0.0060 |
| 412 |
PROTHROMBIN TIME PROLONGED |
36 |
0.0060 |
| 413 |
HYPERKALAEMIA |
209 |
0.0060 |
| 414 |
SHOCK |
137 |
0.0060 |
| 415 |
BRONCHIECTASIS |
40 |
0.0059 |
| 416 |
MALABSORPTION |
31 |
0.0059 |
| 417 |
LIP PAIN |
17 |
0.0059 |
| 418 |
INTRACRANIAL PRESSURE INCREASED |
33 |
0.0059 |
| 419 |
AGRANULOCYTOSIS |
110 |
0.0059 |
| 420 |
SERUM FERRITIN INCREASED |
31 |
0.0059 |
| 421 |
RESPIRATORY DISTRESS |
162 |
0.0059 |
| 422 |
CARDIAC FAILURE ACUTE |
39 |
0.0058 |
| 423 |
SUBCUTANEOUS ABSCESS |
28 |
0.0058 |
| 424 |
ESCHERICHIA INFECTION |
48 |
0.0058 |
| 425 |
CEREBRAL ISCHAEMIA |
30 |
0.0058 |
| 426 |
UVEITIS |
79 |
0.0058 |
| 427 |
ALANINE AMINOTRANSFERASE INCREASED |
356 |
0.0058 |
| 428 |
BLOOD UREA INCREASED |
97 |
0.0058 |
| 429 |
RENAL IMPAIRMENT |
481 |
0.0057 |
| 430 |
TREATMENT FAILURE |
474 |
0.0057 |
| 431 |
ANURIA |
49 |
0.0057 |
| 432 |
BLOOD MAGNESIUM DECREASED |
49 |
0.0057 |
| 433 |
LUNG NEOPLASM |
24 |
0.0056 |
| 434 |
ADRENAL INSUFFICIENCY |
68 |
0.0056 |
| 435 |
SHOCK HAEMORRHAGIC |
45 |
0.0055 |
| 436 |
RENAL FAILURE ACUTE |
234 |
0.0055 |
| 437 |
VENTRICULAR EXTRASYSTOLES |
57 |
0.0055 |
| 438 |
NEUTROPENIA |
746 |
0.0055 |
| 439 |
INTRAOCULAR PRESSURE INCREASED |
70 |
0.0055 |
| 440 |
PERICARDIAL EFFUSION |
125 |
0.0054 |
| 441 |
ACUTE RESPIRATORY FAILURE |
104 |
0.0054 |
| 442 |
LIVER DISORDER |
239 |
0.0054 |
| 443 |
C-REACTIVE PROTEIN INCREASED |
196 |
0.0054 |
| 444 |
ENTEROCOLITIS |
31 |
0.0054 |
| 445 |
ATYPICAL PNEUMONIA |
16 |
0.0053 |
| 446 |
GUILLAIN-BARRE SYNDROME |
25 |
0.0052 |
| 447 |
RHABDOMYOLYSIS |
214 |
0.0051 |
| 448 |
VISUAL FIELD DEFECT |
37 |
0.0051 |
| 449 |
CENTRAL NERVOUS SYSTEM LESION |
70 |
0.0051 |
| 450 |
MENINGITIS |
34 |
0.0051 |
| 451 |
HEMIPARESIS |
86 |
0.0051 |
| 452 |
BLOOD CREATININE INCREASED |
331 |
0.0051 |
| 453 |
HALLUCINATION, AUDITORY |
80 |
0.0050 |
| 454 |
SKIN INFECTION |
56 |
0.0050 |
| 455 |
AUTOIMMUNE HAEMOLYTIC ANAEMIA |
17 |
0.0050 |
| 456 |
OESOPHAGITIS |
54 |
0.0049 |
| 457 |
HEMIPLEGIA |
41 |
0.0049 |
| 458 |
PULMONARY TUBERCULOSIS |
21 |
0.0049 |
| 459 |
ACUTE HEPATIC FAILURE |
67 |
0.0049 |
| 460 |
PLATELET COUNT DECREASED |
522 |
0.0049 |
| 461 |
LEUKOPENIA |
241 |
0.0048 |
| 462 |
DISEASE PROGRESSION |
570 |
0.0048 |
| 463 |
HEPATIC ENZYME ABNORMAL |
24 |
0.0048 |
| 464 |
ACUTE PULMONARY OEDEMA |
27 |
0.0048 |
| 465 |
HAEMORRHAGE SUBCUTANEOUS |
17 |
0.0048 |
| 466 |
VENTRICULAR FIBRILLATION |
53 |
0.0048 |
| 467 |
PSYCHIATRIC SYMPTOM |
35 |
0.0047 |
| 468 |
NERVOUS SYSTEM DISORDER |
148 |
0.0047 |
| 469 |
VISUAL ACUITY REDUCED |
156 |
0.0047 |
| 470 |
ABSCESS LIMB |
20 |
0.0047 |
| 471 |
VENTRICULAR TACHYCARDIA |
77 |
0.0047 |
| 472 |
SINUS TACHYCARDIA |
66 |
0.0046 |
| 473 |
CHRONIC LYMPHOCYTIC LEUKAEMIA |
22 |
0.0046 |
| 474 |
VASCULAR DEVICE INFECTION |
21 |
0.0046 |
| 475 |
LEFT VENTRICULAR DYSFUNCTION |
31 |
0.0046 |
| 476 |
FAILURE TO THRIVE |
24 |
0.0046 |
| 477 |
HEPATITIS ACUTE |
30 |
0.0046 |
| 478 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
181 |
0.0046 |
| 479 |
DEVICE RELATED INFECTION |
70 |
0.0045 |
| 480 |
AZOTAEMIA |
18 |
0.0045 |
| 481 |
ACUTE KIDNEY INJURY |
685 |
0.0045 |
| 482 |
PAPILLOEDEMA |
20 |
0.0044 |
| 483 |
THROMBOCYTOPENIA |
494 |
0.0044 |
| 484 |
LYMPHOCYTE COUNT DECREASED |
78 |
0.0044 |
| 485 |
CHAPPED LIPS |
19 |
0.0044 |
| 486 |
CARDIOPULMONARY FAILURE |
17 |
0.0044 |
| 487 |
SKIN MASS |
29 |
0.0043 |
| 488 |
AMYLASE INCREASED |
16 |
0.0043 |
| 489 |
EMBOLISM |
36 |
0.0043 |
| 490 |
MYELOSUPPRESSION |
156 |
0.0043 |
| 491 |
LEUKOCYTOSIS |
78 |
0.0043 |
| 492 |
HAEMODIALYSIS |
36 |
0.0043 |
| 493 |
HAEMOLYSIS |
33 |
0.0043 |
| 494 |
HYPERTRIGLYCERIDAEMIA |
25 |
0.0043 |
| 495 |
POLYNEUROPATHY |
51 |
0.0043 |
| 496 |
ENTERITIS |
27 |
0.0042 |
| 497 |
CEREBRAL HAEMORRHAGE |
151 |
0.0042 |
| 498 |
LUNG DISORDER |
206 |
0.0042 |
| 499 |
PYREXIA |
1454 |
0.0042 |
| 500 |
PARTIAL SEIZURES |
22 |
0.0042 |
| 501 |
PNEUMONIA |
1358 |
0.0042 |
| 502 |
ILEUS |
52 |
0.0042 |
| 503 |
SUPRAVENTRICULAR TACHYCARDIA |
40 |
0.0042 |
| 504 |
DRUG ERUPTION |
74 |
0.0042 |
| 505 |
ISCHAEMIA |
19 |
0.0041 |
| 506 |
SPLENOMEGALY |
48 |
0.0041 |
| 507 |
INTERSTITIAL LUNG DISEASE |
198 |
0.0041 |
| 508 |
ASCITES |
120 |
0.0041 |
| 509 |
COVID-19 PNEUMONIA |
48 |
0.0041 |
| 510 |
IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME |
24 |
0.0040 |
| 511 |
HYPERCALCAEMIA |
50 |
0.0040 |
| 512 |
SKIN LESION |
111 |
0.0040 |
| 513 |
RENAL FAILURE |
532 |
0.0040 |
| 514 |
VISUAL IMPAIRMENT |
496 |
0.0040 |
| 515 |
HEPATIC ENCEPHALOPATHY |
37 |
0.0040 |
| 516 |
HEPATITIS |
101 |
0.0039 |
| 517 |
MYOPATHY |
34 |
0.0039 |
| 518 |
ATRIAL FLUTTER |
31 |
0.0039 |
| 519 |
MENTAL DISORDER |
169 |
0.0039 |
| 520 |
METABOLIC ACIDOSIS |
124 |
0.0039 |
| 521 |
CONDITION AGGRAVATED |
1157 |
0.0038 |
| 522 |
STREPTOCOCCAL INFECTION |
21 |
0.0038 |
| 523 |
RENAL TUBULAR NECROSIS |
37 |
0.0038 |
| 524 |
BLOOD DISORDER |
30 |
0.0037 |
| 525 |
LIVER FUNCTION TEST INCREASED |
80 |
0.0037 |
| 526 |
SKIN TOXICITY |
21 |
0.0037 |
| 527 |
ATAXIA |
44 |
0.0037 |
| 528 |
OSTEOMYELITIS |
67 |
0.0037 |
| 529 |
PANCREATITIS ACUTE |
83 |
0.0037 |
| 530 |
HYPONATRAEMIA |
207 |
0.0037 |
| 531 |
HEPATIC ENZYME INCREASED |
250 |
0.0037 |
| 532 |
ARTHRITIS INFECTIVE |
17 |
0.0037 |
| 533 |
BREATH SOUNDS ABNORMAL |
18 |
0.0036 |
| 534 |
HYPERGLYCAEMIA |
133 |
0.0036 |
| 535 |
NEPHROTIC SYNDROME |
25 |
0.0036 |
| 536 |
HYPOCALCAEMIA |
69 |
0.0036 |
| 537 |
CIRCULATORY COLLAPSE |
62 |
0.0036 |
| 538 |
DIFFUSE LARGE B-CELL LYMPHOMA |
28 |
0.0036 |
| 539 |
ABDOMINAL TENDERNESS |
18 |
0.0036 |
| 540 |
GENERALISED OEDEMA |
44 |
0.0036 |
| 541 |
GASTROINTESTINAL TOXICITY |
17 |
0.0035 |
| 542 |
HYPERTHERMIA |
27 |
0.0035 |
| 543 |
PNEUMONITIS |
96 |
0.0035 |
| 544 |
RESPIRATORY DISORDER |
105 |
0.0035 |
| 545 |
EOSINOPHILIA |
61 |
0.0035 |
| 546 |
HERPES VIRUS INFECTION |
20 |
0.0035 |
| 547 |
EPILEPSY |
106 |
0.0035 |
| 548 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
30 |
0.0034 |
| 549 |
ORAL DISORDER |
25 |
0.0034 |
| 550 |
INFECTION |
492 |
0.0034 |
| 551 |
MALNUTRITION |
38 |
0.0034 |
| 552 |
THERAPY NON-RESPONDER |
152 |
0.0034 |
| 553 |
FLUID OVERLOAD |
49 |
0.0034 |
| 554 |
ECCHYMOSIS |
23 |
0.0034 |
| 555 |
PETECHIAE |
35 |
0.0034 |
| 556 |
SUBARACHNOID HAEMORRHAGE |
34 |
0.0033 |
| 557 |
SEROTONIN SYNDROME |
64 |
0.0033 |
| 558 |
SINUS BRADYCARDIA |
32 |
0.0033 |
| 559 |
AUTOIMMUNE HEPATITIS |
23 |
0.0033 |
| 560 |
DRUG INEFFECTIVE |
4334 |
0.0033 |
| 561 |
STEVENS-JOHNSON SYNDROME |
73 |
0.0033 |
| 562 |
CEREBRAL INFARCTION |
80 |
0.0033 |
| 563 |
LYMPHOMA |
50 |
0.0032 |
| 564 |
MYOSITIS |
29 |
0.0032 |
| 565 |
WHITE BLOOD CELL COUNT DECREASED |
350 |
0.0032 |
| 566 |
RESPIRATORY TRACT INFECTION |
84 |
0.0032 |
| 567 |
NEUTROPHIL COUNT INCREASED |
33 |
0.0032 |
| 568 |
LUPUS-LIKE SYNDROME |
29 |
0.0032 |
| 569 |
HICCUPS |
26 |
0.0032 |
| 570 |
SKIN CANCER |
68 |
0.0032 |
| 571 |
HAEMATOTOXICITY |
30 |
0.0032 |
| 572 |
CARDIOTOXICITY |
28 |
0.0031 |
| 573 |
WHITE BLOOD CELL COUNT ABNORMAL |
20 |
0.0031 |
| 574 |
ABSCESS |
50 |
0.0031 |
| 575 |
NORMAL NEWBORN |
17 |
0.0031 |
| 576 |
HAEMOLYTIC ANAEMIA |
28 |
0.0031 |
| 577 |
JAUNDICE |
84 |
0.0031 |
| 578 |
CHOLECYSTITIS |
37 |
0.0031 |
| 579 |
RENAL DISORDER |
144 |
0.0031 |
| 580 |
PRODUCT USE IN UNAPPROVED INDICATION |
765 |
0.0031 |
| 581 |
MOUTH ULCERATION |
65 |
0.0031 |
| 582 |
CLOSTRIDIUM DIFFICILE INFECTION |
67 |
0.0031 |
| 583 |
DECUBITUS ULCER |
25 |
0.0031 |
| 584 |
PULMONARY OEDEMA |
136 |
0.0030 |
| 585 |
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY |
25 |
0.0030 |
| 586 |
DISORIENTATION |
120 |
0.0030 |
| 587 |
HAEMATOCRIT DECREASED |
60 |
0.0030 |
| 588 |
DISEASE RECURRENCE |
143 |
0.0030 |
| 589 |
PERITONITIS |
62 |
0.0030 |
| 590 |
COMPRESSION FRACTURE |
16 |
0.0030 |
| 591 |
BLOOD POTASSIUM DECREASED |
89 |
0.0030 |
| 592 |
AGITATION |
217 |
0.0030 |
| 593 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
85 |
0.0029 |
| 594 |
BLOOD URIC ACID INCREASED |
17 |
0.0029 |
| 595 |
HAEMORRHAGE INTRACRANIAL |
44 |
0.0029 |
| 596 |
CARDIAC FAILURE |
235 |
0.0029 |
| 597 |
CARDIAC ARREST |
240 |
0.0029 |
| 598 |
GENERALISED TONIC-CLONIC SEIZURE |
48 |
0.0029 |
| 599 |
ANAEMIA |
552 |
0.0029 |
| 600 |
LARGE INTESTINE PERFORATION |
20 |
0.0029 |
| 601 |
OFF LABEL USE |
2510 |
0.0029 |
| 602 |
MOUTH HAEMORRHAGE |
21 |
0.0029 |
| 603 |
CONFUSIONAL STATE |
460 |
0.0028 |
| 604 |
HYPERLIPIDAEMIA |
34 |
0.0028 |
| 605 |
IMMUNODEFICIENCY |
42 |
0.0028 |
| 606 |
FACIAL PARALYSIS |
24 |
0.0028 |
| 607 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
17 |
0.0028 |
| 608 |
PRODUCTIVE COUGH |
133 |
0.0028 |
| 609 |
TRANSFUSION |
29 |
0.0028 |
| 610 |
COMA |
131 |
0.0027 |
| 611 |
WOUND INFECTION |
30 |
0.0027 |
| 612 |
NEUROPATHY PERIPHERAL |
260 |
0.0027 |
| 613 |
PURPURA |
24 |
0.0027 |
| 614 |
UNRESPONSIVE TO STIMULI |
70 |
0.0027 |
| 615 |
CELLULITIS |
136 |
0.0027 |
| 616 |
VASCULITIS |
31 |
0.0027 |
| 617 |
STATUS EPILEPTICUS |
30 |
0.0027 |
| 618 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
68 |
0.0026 |
| 619 |
SPUTUM DISCOLOURED |
25 |
0.0026 |
| 620 |
HOSPICE CARE |
26 |
0.0026 |
| 621 |
URINE OUTPUT DECREASED |
23 |
0.0026 |
| 622 |
EYE MOVEMENT DISORDER |
18 |
0.0026 |
| 623 |
INCOHERENT |
17 |
0.0026 |
| 624 |
CONCOMITANT DISEASE AGGRAVATED |
16 |
0.0026 |
| 625 |
RESPIRATORY RATE INCREASED |
23 |
0.0026 |
| 626 |
RED BLOOD CELL COUNT DECREASED |
74 |
0.0026 |
| 627 |
CARDIO-RESPIRATORY ARREST |
108 |
0.0026 |
| 628 |
VISION BLURRED |
350 |
0.0025 |
| 629 |
NO THERAPEUTIC RESPONSE |
31 |
0.0025 |
| 630 |
WHITE BLOOD CELL COUNT INCREASED |
97 |
0.0025 |
| 631 |
MYDRIASIS |
32 |
0.0025 |
| 632 |
RESTLESSNESS |
91 |
0.0025 |
| 633 |
HAEMATURIA |
85 |
0.0025 |
| 634 |
TOXICITY TO VARIOUS AGENTS |
418 |
0.0025 |
| 635 |
NEPHROPATHY |
23 |
0.0025 |
| 636 |
HAEMOGLOBIN DECREASED |
252 |
0.0025 |
| 637 |
SKIN HYPERPIGMENTATION |
21 |
0.0024 |
| 638 |
VITREOUS FLOATERS |
24 |
0.0024 |
| 639 |
BLINDNESS |
99 |
0.0024 |
| 640 |
HYPOTENSION |
485 |
0.0024 |
| 641 |
HYPOGLYCAEMIA |
117 |
0.0024 |
| 642 |
INTESTINAL PERFORATION |
27 |
0.0024 |
| 643 |
ATRIAL FIBRILLATION |
234 |
0.0024 |
| 644 |
GENERAL PHYSICAL HEALTH DETERIORATION |
273 |
0.0024 |
| 645 |
ORAL CANDIDIASIS |
31 |
0.0024 |
| 646 |
APHASIA |
71 |
0.0023 |
| 647 |
DRUG TOXICITY |
32 |
0.0023 |
| 648 |
OEDEMA |
127 |
0.0023 |
| 649 |
DIALYSIS |
33 |
0.0023 |
| 650 |
BLOOD CALCIUM DECREASED |
26 |
0.0023 |
| 651 |
EYE PAIN |
130 |
0.0023 |
| 652 |
BLISTER |
126 |
0.0022 |
| 653 |
TACHYCARDIA |
199 |
0.0022 |
| 654 |
MELAENA |
49 |
0.0022 |
| 655 |
BLOOD POTASSIUM INCREASED |
36 |
0.0022 |
| 656 |
MITRAL VALVE INCOMPETENCE |
25 |
0.0022 |
| 657 |
ATRIOVENTRICULAR BLOCK |
17 |
0.0022 |
| 658 |
FULL BLOOD COUNT DECREASED |
44 |
0.0022 |
| 659 |
ORTHOSTATIC HYPOTENSION |
38 |
0.0022 |
| 660 |
THERAPY PARTIAL RESPONDER |
34 |
0.0022 |
| 661 |
HAEMORRHAGIC STROKE |
17 |
0.0022 |
| 662 |
ANOREXIA |
28 |
0.0022 |
| 663 |
SUBDURAL HAEMATOMA |
31 |
0.0022 |
| 664 |
COLITIS |
82 |
0.0022 |
| 665 |
BODY TEMPERATURE INCREASED |
44 |
0.0022 |
| 666 |
BRADYCARDIA |
114 |
0.0021 |
| 667 |
HEPATIC STEATOSIS |
40 |
0.0021 |
| 668 |
TRICUSPID VALVE INCOMPETENCE |
17 |
0.0021 |
| 669 |
IMMUNE SYSTEM DISORDER |
28 |
0.0021 |
| 670 |
DRUG INTOLERANCE |
202 |
0.0021 |
| 671 |
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS |
16 |
0.0021 |
| 672 |
BLINDNESS UNILATERAL |
29 |
0.0021 |
| 673 |
OEDEMA PERIPHERAL |
250 |
0.0020 |
| 674 |
RASH ERYTHEMATOUS |
98 |
0.0020 |
| 675 |
PRODUCT USE ISSUE |
383 |
0.0020 |
| 676 |
DYSARTHRIA |
76 |
0.0020 |
| 677 |
HYPOTONIA |
20 |
0.0020 |
| 678 |
NODULE |
26 |
0.0020 |
| 679 |
GASTROINTESTINAL HAEMORRHAGE |
166 |
0.0020 |
| 680 |
EYELID OEDEMA |
23 |
0.0020 |
| 681 |
PULMONARY CONGESTION |
26 |
0.0020 |
| 682 |
INTERNATIONAL NORMALISED RATIO INCREASED |
56 |
0.0020 |
| 683 |
PRESCRIBED OVERDOSE |
38 |
0.0020 |
| 684 |
CARDIOMYOPATHY |
29 |
0.0020 |
| 685 |
PYELONEPHRITIS |
17 |
0.0020 |
| 686 |
PNEUMONIA ASPIRATION |
49 |
0.0020 |
| 687 |
RETINAL DETACHMENT |
18 |
0.0020 |
| 688 |
CARDIOGENIC SHOCK |
28 |
0.0019 |
| 689 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
138 |
0.0019 |
| 690 |
OXYGEN SATURATION DECREASED |
109 |
0.0019 |
| 691 |
SKIN DISORDER |
64 |
0.0019 |
| 692 |
BLOOD COUNT ABNORMAL |
29 |
0.0019 |
| 693 |
FACE OEDEMA |
32 |
0.0019 |
| 694 |
OBSTRUCTIVE AIRWAYS DISORDER |
21 |
0.0019 |
| 695 |
STOMATITIS |
114 |
0.0019 |
| 696 |
CONVULSION |
107 |
0.0019 |
| 697 |
OCULAR DISCOMFORT |
21 |
0.0019 |
| 698 |
BONE DISORDER |
34 |
0.0019 |
| 699 |
MOTOR DYSFUNCTION |
19 |
0.0019 |
| 700 |
HYPOPHAGIA |
47 |
0.0018 |
| 701 |
ERYTHEMA MULTIFORME |
17 |
0.0018 |
| 702 |
HAEMATOMA |
47 |
0.0018 |
| 703 |
NEOPLASM PROGRESSION |
63 |
0.0018 |
| 704 |
BLOOD PRESSURE DECREASED |
120 |
0.0018 |
| 705 |
BLOOD SODIUM DECREASED |
34 |
0.0018 |
| 706 |
EJECTION FRACTION DECREASED |
28 |
0.0018 |
| 707 |
PANCREATITIS |
95 |
0.0018 |
| 708 |
SMALL INTESTINAL OBSTRUCTION |
22 |
0.0018 |
| 709 |
BLOOD TEST ABNORMAL |
25 |
0.0018 |
| 710 |
TUBULOINTERSTITIAL NEPHRITIS |
33 |
0.0018 |
| 711 |
HEPATIC CIRRHOSIS |
33 |
0.0018 |
| 712 |
MUSCLE ATROPHY |
22 |
0.0017 |
| 713 |
DEATH |
1483 |
0.0017 |
| 714 |
VIRAL INFECTION |
57 |
0.0017 |
| 715 |
SUDDEN DEATH |
18 |
0.0017 |
| 716 |
PHARYNGITIS |
21 |
0.0017 |
| 717 |
BONE PAIN |
98 |
0.0017 |
| 718 |
EYELID PTOSIS |
17 |
0.0017 |
| 719 |
ARRHYTHMIA |
79 |
0.0017 |
| 720 |
CHROMATURIA |
37 |
0.0016 |
| 721 |
INTENTIONAL PRODUCT USE ISSUE |
142 |
0.0016 |
| 722 |
HAEMATEMESIS |
41 |
0.0016 |
| 723 |
DIPLOPIA |
42 |
0.0016 |
| 724 |
INFLAMMATION |
83 |
0.0016 |
| 725 |
DEAFNESS |
42 |
0.0016 |
| 726 |
GASTROENTERITIS |
23 |
0.0016 |
| 727 |
DYSURIA |
58 |
0.0016 |
| 728 |
SKIN EXFOLIATION |
132 |
0.0016 |
| 729 |
CHOLELITHIASIS |
51 |
0.0016 |
| 730 |
LYMPHADENOPATHY |
55 |
0.0016 |
| 731 |
CARDIOMEGALY |
19 |
0.0015 |
| 732 |
DYSPHAGIA |
146 |
0.0015 |
| 733 |
PULMONARY HYPERTENSION |
32 |
0.0015 |
| 734 |
COUGH |
430 |
0.0015 |
| 735 |
PULMONARY FIBROSIS |
29 |
0.0015 |
| 736 |
DECREASED APPETITE |
350 |
0.0015 |
| 737 |
DERMATITIS |
31 |
0.0015 |
| 738 |
BRONCHOSPASM |
21 |
0.0015 |
| 739 |
PRODUCT PRESCRIBING ISSUE |
32 |
0.0015 |
| 740 |
MANIA |
24 |
0.0015 |
| 741 |
TREMOR |
242 |
0.0015 |
| 742 |
ERYTHEMA |
298 |
0.0014 |
| 743 |
GASTROINTESTINAL DISORDER |
129 |
0.0014 |
| 744 |
THERAPEUTIC RESPONSE DECREASED |
87 |
0.0014 |
| 745 |
LABORATORY TEST ABNORMAL |
42 |
0.0014 |
| 746 |
PROTEINURIA |
27 |
0.0014 |
| 747 |
DEHYDRATION |
188 |
0.0014 |
| 748 |
POST PROCEDURAL COMPLICATION |
27 |
0.0014 |
| 749 |
RASH PAPULAR |
31 |
0.0014 |
| 750 |
RESPIRATORY ARREST |
38 |
0.0014 |
| 751 |
CHILLS |
161 |
0.0014 |
| 752 |
MUSCULAR WEAKNESS |
156 |
0.0014 |
| 753 |
BEDRIDDEN |
18 |
0.0014 |
| 754 |
PERICARDITIS |
23 |
0.0014 |
| 755 |
MASS |
19 |
0.0014 |
| 756 |
DERMATITIS ALLERGIC |
17 |
0.0014 |
| 757 |
DYSPNOEA |
758 |
0.0013 |
| 758 |
SEIZURE |
154 |
0.0013 |
| 759 |
ORAL HERPES |
26 |
0.0013 |
| 760 |
HERPES ZOSTER |
76 |
0.0013 |
| 761 |
SPEECH DISORDER |
69 |
0.0013 |
| 762 |
NEURALGIA |
32 |
0.0013 |
| 763 |
GASTRIC ULCER |
25 |
0.0013 |
| 764 |
SKIN ULCER |
34 |
0.0013 |
| 765 |
CONTRAINDICATED PRODUCT ADMINISTERED |
39 |
0.0013 |
| 766 |
ABDOMINAL PAIN |
299 |
0.0013 |
| 767 |
BALANCE DISORDER |
111 |
0.0013 |
| 768 |
EPISTAXIS |
96 |
0.0013 |
| 769 |
FEEDING DISORDER |
26 |
0.0013 |
| 770 |
LOWER RESPIRATORY TRACT INFECTION |
58 |
0.0013 |
| 771 |
DEEP VEIN THROMBOSIS |
82 |
0.0013 |
| 772 |
TREATMENT NONCOMPLIANCE |
69 |
0.0013 |
| 773 |
VOMITING |
591 |
0.0013 |
| 774 |
HAEMORRHAGE |
131 |
0.0013 |
| 775 |
ORAL PAIN |
28 |
0.0012 |
| 776 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
21 |
0.0012 |
| 777 |
DYSPNOEA EXERTIONAL |
47 |
0.0012 |
| 778 |
ABNORMAL BEHAVIOUR |
49 |
0.0012 |
| 779 |
BRONCHITIS |
90 |
0.0012 |
| 780 |
BRAIN FOG |
19 |
0.0012 |
| 781 |
HYPOACUSIS |
52 |
0.0012 |
| 782 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
63 |
0.0012 |
| 783 |
DIARRHOEA |
778 |
0.0012 |
| 784 |
FAECES DISCOLOURED |
26 |
0.0012 |
| 785 |
SINUSITIS |
122 |
0.0012 |
| 786 |
PARALYSIS |
17 |
0.0012 |
| 787 |
PLASMA CELL MYELOMA |
46 |
0.0012 |
| 788 |
INFUSION RELATED REACTION |
77 |
0.0012 |
| 789 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
34 |
0.0012 |
| 790 |
RASH GENERALISED |
30 |
0.0012 |
| 791 |
EYE DISORDER |
38 |
0.0012 |
| 792 |
COORDINATION ABNORMAL |
16 |
0.0011 |
| 793 |
RASH |
500 |
0.0011 |
| 794 |
INTERVERTEBRAL DISC PROTRUSION |
25 |
0.0011 |
| 795 |
LACTIC ACIDOSIS |
37 |
0.0011 |
| 796 |
GLAUCOMA |
22 |
0.0011 |
| 797 |
ASTHENIA |
429 |
0.0011 |
| 798 |
TASTE DISORDER |
23 |
0.0011 |
| 799 |
CONJUNCTIVITIS |
21 |
0.0011 |
| 800 |
CYSTITIS |
36 |
0.0011 |
| 801 |
CONSTIPATION |
246 |
0.0011 |
| 802 |
HAEMORRHOIDS |
22 |
0.0011 |
| 803 |
SENSORY DISTURBANCE |
18 |
0.0011 |
| 804 |
ABDOMINAL DISTENSION |
117 |
0.0011 |
| 805 |
FLUID RETENTION |
57 |
0.0011 |
| 806 |
OSTEOPENIA |
17 |
0.0011 |
| 807 |
SOMNOLENCE |
222 |
0.0011 |
| 808 |
MYALGIA |
187 |
0.0011 |
| 809 |
SPINAL FRACTURE |
22 |
0.0011 |
| 810 |
LETHARGY |
63 |
0.0011 |
| 811 |
HEART RATE INCREASED |
108 |
0.0011 |
| 812 |
WEIGHT DECREASED |
304 |
0.0011 |
| 813 |
MALIGNANT NEOPLASM PROGRESSION |
111 |
0.0011 |
| 814 |
CYANOSIS |
17 |
0.0011 |
| 815 |
NIGHTMARE |
37 |
0.0011 |
| 816 |
AGGRESSION |
53 |
0.0011 |
| 817 |
COGNITIVE DISORDER |
49 |
0.0010 |
| 818 |
LOSS OF CONSCIOUSNESS |
133 |
0.0010 |
| 819 |
LOCALISED INFECTION |
25 |
0.0010 |
| 820 |
HYPOTHYROIDISM |
33 |
0.0010 |
| 821 |
HIP FRACTURE |
33 |
0.0010 |
| 822 |
GASTRITIS |
27 |
0.0010 |
| 823 |
HYPERTENSION |
217 |
0.0010 |
| 824 |
PSYCHOMOTOR HYPERACTIVITY |
17 |
0.0010 |
| 825 |
PSYCHOTIC DISORDER |
30 |
0.0010 |
| 826 |
ACTIVITIES OF DAILY LIVING IMPAIRED |
20 |
0.0010 |
| 827 |
GALLBLADDER DISORDER |
18 |
0.0010 |
| 828 |
PRODUCT PRESCRIBING ERROR |
24 |
0.0010 |
| 829 |
NAUSEA |
795 |
0.0010 |
| 830 |
NEOPLASM MALIGNANT |
67 |
0.0010 |
| 831 |
MUSCLE TWITCHING |
23 |
0.0010 |
| 832 |
DRUG EFFECT INCOMPLETE |
36 |
0.0010 |
| 833 |
MUSCULOSKELETAL DISCOMFORT |
17 |
0.0010 |
| 834 |
INFLUENZA |
110 |
0.0010 |
| 835 |
PARAESTHESIA |
154 |
0.0010 |
| 836 |
PULMONARY EMBOLISM |
93 |
0.0010 |
| 837 |
LOCAL SWELLING |
17 |
0.0010 |
| 838 |
UPPER RESPIRATORY TRACT INFECTION |
45 |
0.0010 |
| 839 |
DIABETES MELLITUS |
74 |
0.0010 |
| 840 |
DISTURBANCE IN ATTENTION |
52 |
0.0010 |
| 841 |
WHEEZING |
57 |
0.0010 |
| 842 |
BLOOD PRESSURE FLUCTUATION |
23 |
0.0010 |
| 843 |
ACUTE MYOCARDIAL INFARCTION |
28 |
0.0009 |
| 844 |
ABNORMAL DREAMS |
26 |
0.0009 |
| 845 |
CHEST PAIN |
173 |
0.0009 |
| 846 |
THROMBOSIS |
75 |
0.0009 |
| 847 |
NIGHT SWEATS |
30 |
0.0009 |
| 848 |
FREQUENT BOWEL MOVEMENTS |
25 |
0.0009 |
| 849 |
SWELLING FACE |
60 |
0.0009 |
| 850 |
GAIT DISTURBANCE |
176 |
0.0009 |
| 851 |
RENAL INJURY |
27 |
0.0009 |
| 852 |
CARDIOVASCULAR DISORDER |
23 |
0.0009 |
| 853 |
BLOOD TRIGLYCERIDES INCREASED |
16 |
0.0009 |
| 854 |
HYPOAESTHESIA |
135 |
0.0009 |
| 855 |
INSOMNIA |
238 |
0.0009 |
| 856 |
URINARY TRACT INFECTION |
151 |
0.0009 |
| 857 |
ACCIDENTAL OVERDOSE |
32 |
0.0009 |
| 858 |
COVID-19 |
153 |
0.0009 |
| 859 |
CARDIAC FAILURE CONGESTIVE |
70 |
0.0009 |
| 860 |
PRESYNCOPE |
21 |
0.0009 |
| 861 |
ANGIOEDEMA |
38 |
0.0009 |
| 862 |
ANAPHYLACTIC REACTION |
47 |
0.0008 |
| 863 |
URINARY RETENTION |
28 |
0.0008 |
| 864 |
DYSKINESIA |
34 |
0.0008 |
| 865 |
POOR QUALITY SLEEP |
18 |
0.0008 |
| 866 |
HAEMATOCHEZIA |
46 |
0.0008 |
| 867 |
DRUG ADMINISTRATION ERROR |
25 |
0.0008 |
| 868 |
MALAISE |
356 |
0.0008 |
| 869 |
PALLOR |
22 |
0.0008 |
| 870 |
LUNG NEOPLASM MALIGNANT |
33 |
0.0008 |
| 871 |
SYNCOPE |
80 |
0.0008 |
| 872 |
HEART RATE DECREASED |
28 |
0.0008 |
| 873 |
LACRIMATION INCREASED |
24 |
0.0008 |
| 874 |
FALL |
264 |
0.0008 |
| 875 |
CHEST DISCOMFORT |
81 |
0.0008 |
| 876 |
RASH MACULAR |
27 |
0.0008 |
| 877 |
ABASIA |
19 |
0.0008 |
| 878 |
ALOPECIA |
149 |
0.0008 |
| 879 |
CATARACT |
45 |
0.0008 |
| 880 |
OVERDOSE |
163 |
0.0008 |
| 881 |
OSTEOPOROSIS |
31 |
0.0008 |
| 882 |
URINARY INCONTINENCE |
22 |
0.0007 |
| 883 |
BACK PAIN |
172 |
0.0007 |
| 884 |
CARDIAC DISORDER |
68 |
0.0007 |
| 885 |
RASH PRURITIC |
39 |
0.0007 |
| 886 |
DYSSTASIA |
21 |
0.0007 |
| 887 |
SKIN DISCOLOURATION |
33 |
0.0007 |
| 888 |
MEMORY IMPAIRMENT |
97 |
0.0007 |
| 889 |
MENTAL IMPAIRMENT |
17 |
0.0007 |
| 890 |
WEIGHT INCREASED |
157 |
0.0007 |
| 891 |
LIMB INJURY |
19 |
0.0007 |
| 892 |
HEADACHE |
433 |
0.0007 |
| 893 |
MOVEMENT DISORDER |
22 |
0.0007 |
| 894 |
WOUND |
19 |
0.0007 |
| 895 |
AMNESIA |
44 |
0.0007 |
| 896 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
24 |
0.0007 |
| 897 |
NEPHROLITHIASIS |
31 |
0.0007 |
| 898 |
HYPERHIDROSIS |
87 |
0.0007 |
| 899 |
ARTHRITIS |
53 |
0.0007 |
| 900 |
DIZZINESS |
336 |
0.0007 |
| 901 |
VERTIGO |
41 |
0.0007 |
| 902 |
MUSCULOSKELETAL PAIN |
35 |
0.0007 |
| 903 |
HYPERSENSITIVITY |
124 |
0.0007 |
| 904 |
ABDOMINAL DISCOMFORT |
112 |
0.0007 |
| 905 |
HEAD INJURY |
21 |
0.0007 |
| 906 |
INTESTINAL OBSTRUCTION |
25 |
0.0007 |
| 907 |
NERVOUSNESS |
34 |
0.0007 |
| 908 |
SEDATION |
17 |
0.0006 |
| 909 |
ASTHMA |
73 |
0.0006 |
| 910 |
PERIPHERAL SWELLING |
97 |
0.0006 |
| 911 |
FATIGUE |
489 |
0.0006 |
| 912 |
BURNING SENSATION |
44 |
0.0006 |
| 913 |
ILL-DEFINED DISORDER |
38 |
0.0006 |
| 914 |
HOSPITALISATION |
96 |
0.0006 |
| 915 |
GYNAECOMASTIA |
19 |
0.0006 |
| 916 |
NASAL CONGESTION |
36 |
0.0006 |
| 917 |
ABDOMINAL PAIN UPPER |
126 |
0.0006 |
| 918 |
MEDICATION ERROR |
34 |
0.0006 |
| 919 |
COLITIS ULCERATIVE |
27 |
0.0006 |
| 920 |
POLLAKIURIA |
25 |
0.0006 |
| 921 |
DEPRESSION |
136 |
0.0006 |
| 922 |
OROPHARYNGEAL PAIN |
55 |
0.0006 |
| 923 |
EYE SWELLING |
22 |
0.0006 |
| 924 |
ARTHRALGIA |
243 |
0.0006 |
| 925 |
SLEEP DISORDER |
41 |
0.0006 |
| 926 |
DIVERTICULITIS |
16 |
0.0006 |
| 927 |
CONTUSION |
55 |
0.0006 |
| 928 |
LIP SWELLING |
19 |
0.0006 |
| 929 |
THERAPEUTIC RESPONSE UNEXPECTED |
25 |
0.0006 |
| 930 |
DRY MOUTH |
45 |
0.0006 |
| 931 |
PAIN IN EXTREMITY |
158 |
0.0005 |
| 932 |
INTENTIONAL PRODUCT MISUSE |
46 |
0.0005 |
| 933 |
SWELLING |
49 |
0.0005 |
| 934 |
OSTEONECROSIS |
17 |
0.0005 |
| 935 |
BLOOD PRESSURE INCREASED |
79 |
0.0005 |
| 936 |
RHINORRHOEA |
33 |
0.0005 |
| 937 |
MATERNAL EXPOSURE DURING PREGNANCY |
45 |
0.0005 |
| 938 |
CEREBROVASCULAR ACCIDENT |
85 |
0.0005 |
| 939 |
TINNITUS |
23 |
0.0005 |
| 940 |
CHRONIC KIDNEY DISEASE |
38 |
0.0005 |
| 941 |
IRRITABILITY |
30 |
0.0005 |
| 942 |
MUSCLE SPASMS |
91 |
0.0005 |
| 943 |
FEELING ABNORMAL |
118 |
0.0005 |
| 944 |
UNEVALUABLE EVENT |
37 |
0.0005 |
| 945 |
PALPITATIONS |
55 |
0.0005 |
| 946 |
DRUG EFFECT DECREASED |
25 |
0.0005 |
| 947 |
NO ADVERSE EVENT |
84 |
0.0005 |
| 948 |
INFLUENZA LIKE ILLNESS |
38 |
0.0005 |
| 949 |
DYSPHONIA |
27 |
0.0005 |
| 950 |
FLATULENCE |
26 |
0.0005 |
| 951 |
PAIN |
274 |
0.0004 |
| 952 |
ADVERSE DRUG REACTION |
40 |
0.0004 |
| 953 |
DISCOMFORT |
27 |
0.0004 |
| 954 |
ILLNESS |
44 |
0.0004 |
| 955 |
DYSPEPSIA |
42 |
0.0004 |
| 956 |
PRURITUS |
164 |
0.0004 |
| 957 |
ADVERSE EVENT |
39 |
0.0004 |
| 958 |
OCULAR HYPERAEMIA |
20 |
0.0004 |
| 959 |
BLOOD GLUCOSE DECREASED |
20 |
0.0004 |
| 960 |
NASOPHARYNGITIS |
76 |
0.0004 |
| 961 |
BLOOD GLUCOSE INCREASED |
77 |
0.0004 |
| 962 |
ANXIETY |
116 |
0.0004 |
| 963 |
JOINT SWELLING |
49 |
0.0004 |
| 964 |
THROAT IRRITATION |
18 |
0.0004 |
| 965 |
NECK PAIN |
22 |
0.0004 |
| 966 |
DYSGEUSIA |
29 |
0.0004 |
| 967 |
GASTROOESOPHAGEAL REFLUX DISEASE |
31 |
0.0004 |
| 968 |
MOBILITY DECREASED |
27 |
0.0004 |
| 969 |
SUICIDAL IDEATION |
33 |
0.0004 |
| 970 |
DRY SKIN |
48 |
0.0004 |
| 971 |
URTICARIA |
58 |
0.0003 |
| 972 |
HOT FLUSH |
26 |
0.0003 |
| 973 |
ARTHROPATHY |
19 |
0.0003 |
| 974 |
PRODUCT DOSE OMISSION |
22 |
0.0003 |
| 975 |
FLUSHING |
34 |
0.0003 |
| 976 |
UNDERDOSE |
24 |
0.0003 |
| 977 |
DRY EYE |
16 |
0.0003 |
| 978 |
INTENTIONAL OVERDOSE |
19 |
0.0003 |
| 979 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
52 |
0.0003 |
| 980 |
MYOCARDIAL INFARCTION |
50 |
0.0003 |
| 981 |
FOETAL EXPOSURE DURING PREGNANCY |
23 |
0.0003 |
| 982 |
ACNE |
21 |
0.0003 |
| 983 |
PRODUCT DOSE OMISSION ISSUE |
80 |
0.0003 |
| 984 |
FEELING HOT |
16 |
0.0003 |
| 985 |
EXPOSURE DURING PREGNANCY |
16 |
0.0003 |
| 986 |
INCORRECT DOSE ADMINISTERED |
58 |
0.0003 |
| 987 |
THERAPY INTERRUPTED |
18 |
0.0003 |
| 988 |
MIGRAINE |
20 |
0.0002 |
| 989 |
MUSCULOSKELETAL STIFFNESS |
18 |
0.0002 |
| 990 |
EMOTIONAL DISTRESS |
23 |
0.0002 |
| 991 |
DRUG DOSE OMISSION |
31 |
0.0002 |
| 992 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
38 |
0.0002 |
| 993 |
ACCIDENTAL EXPOSURE TO PRODUCT |
18 |
0.0002 |
| 994 |
RHEUMATOID ARTHRITIS |
17 |
0.0001 |